The Novo Nordisk Foundation, which controls drug maker Novo Nordisk, said it would commit up to 1.8 billion Danish crowns ($265 million) to setting up an initiative aimed at improving vaccines for respiratory diseases.
Tag Archive for: Drug development
It is the biggest change to existing medical laws in two decades, aiming to ensure all Europeans have access to innovative treatments and drugs.
Clinical trials continue to experience a paucity of diversity, but it will take a multipronged approach to infuse DEI into research.
In its most basic form, market access means ensuring patients can physically get a product. Sounds simple, right?
Following a nine-month review, the Biden administration will issue a framework for the National Institutes of Health to implement so-called “march-in rights” under the Bayh-Dole Act of 1980.
In recent years, J&J has pumped hundreds of millions of dollars into its artificial intelligence (AI) capabilities, according to the WSJ, including bringing on some 6,000 data science and digital specialists and erecting a “cutting-edge” research facility in the San Francisco Bay Area, which it opened in September 2022.
Predictions from Pamela Tenaerts, M.D., chief scientific officer and Alison Holland, executive GM of customer value, Medable.
A pair of new initiatives are infusing money into life sciences innovation in New York at a time when biotech funding is generally scarce. Together, the recently-announced projects, spearheaded by the state and the Chan Zuckerberg Initiative, will bring about $370 million in funding to biotech in the Empire State.
The blood-brain barrier: It’s neuroscience’s next frontier, and a presentation on Roche’s trontinemab at the Clinical Trials on Alzheimer’s Disease conference last month sparked new optimism that researchers might be getting close to breaking through it.
For $80 million upfront and the promise of more than $1.2 billion in milestones, Novartis has bought the global rights to develop an oral HDAC6 inhibitor from Chong Kun Dang Pharmaceutical.
